Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma

With the increasing promise of long-term survival with immune checkpoint blockade (ICB) therapies, particularly for patients with advanced melanoma, clinicians and investigators are driven to identify prognostic and predictive factors that may help to identify individuals who are likely to experienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Loo, Kimberly, Smithy, James W., Postow, Michael A., Betof Warner, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787112/
https://www.ncbi.nlm.nih.gov/pubmed/35087529
http://dx.doi.org/10.3389/fimmu.2021.810388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787112/
https://www.ncbi.nlm.nih.gov/pubmed/35087529
http://dx.doi.org/10.3389/fimmu.2021.810388

Ejemplares similares